QYResearch: Europe and North America Chlorhexidine Gluconate (CHG) Solution Market Report 2017 Overview
Chlorhexidine Gluconate (CHG) Solution has been used in more than 60 different pharmaceuticals and medical devices. Its wide application is due to its broad-spectrum efficacy, safety-profile and substantivity on the skin with low irritation. It has been found to possess a high level of antimicrobial activity and strong affinity for binding to skin and mucous membranes.
Demand from the downstream brings a power to the development of Chlorhexidine Gluconate Solution industry. Europe and North America are the major consumption market of Chlorhexidine Gluconate Solution. In recent years, growing China market became an important market of Chlorhexidine Gluconate Solution.
By types, CHG 2% Solution and CHG 4% Solution are the two biggest types, in 2016, CHG 2% Solution accounted for about 44.17%, and CHG 4% Solution accounted for about 39.53%.
By application, Surgical Preparation is the biggest application, in 2016, Surgical Preparation occupied about 32.96% consumption share. And in 2016 Skin Preparation accounted for about 28.59% of the consumption share.
Viewed from the supply side, there are some manufacturers in the Chlorhexidine Gluconate Solution industry such as Xttrium, Medichem, Clorox Healthcare, Becton Dickinson Co, Bajaj Medical, MölnlyckeHealth Care, 3M, Ecolab, Sage Prods, STERIS, Maxil, Pharmaceutical Product, etc. And Xttrium is the biggest supplier, in 2016, Xttrium occupied about 19.10% production share.
The total Europe and North America CHG solution in 2016 was about 42.58 Million USD, and in 2017, QYR predict that the market size in Europe and North America will be about 43.59 million USD.
This article was first released by QYResearch, if reproduced, please indicate the source.
Marketing: sales@qyresearch.com
Media Contact: press@qyresearch.com
评论
发表评论